IONS logo

IONS
Ionis Pharmaceuticals Inc

6,630
Mkt Cap
$12.32B
Volume
2.08M
52W High
$76.78
52W Low
$23.95
PE Ratio
-44.46
IONS Fundamentals
Price
$76.06
Prev Close
$73.12
Open
$73.00
50D MA
$69.69
Beta
0.70
Avg. Volume
2.11M
EPS (Annual)
-$3.04
P/B
19.84
Rev/Employee
$659,623.95
Loading...
Loading...
News
all
press releases
Frank Rimerman Advisors LLC Takes $228,000 Position in Ionis Pharmaceuticals, Inc. $IONS
Frank Rimerman Advisors LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Leerink Partnrs Has Pessimistic View of IONS FY2026 Earnings
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) - Research analysts at Leerink Partnrs dropped their FY2026 earnings estimates for Ionis Pharmaceuticals in a research report issued on...
MarketBeat·1d ago
News Placeholder
Pinnacle Wealth Planning Services Inc. Makes New Investment in Ionis Pharmaceuticals, Inc. $IONS
Pinnacle Wealth Planning Services Inc. bought a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the second quarter, according to its most recent filing with the...
MarketBeat·1d ago
News Placeholder
Savant Capital LLC Acquires Shares of 5,607 Ionis Pharmaceuticals, Inc. $IONS
Savant Capital LLC bought a new position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the second quarter, according to the company in its most recent filing with the...
MarketBeat·3d ago
News Placeholder
Ionis Pharmaceuticals, Inc. $IONS Stock Holdings Increased by Raiffeisen Bank International AG
Raiffeisen Bank International AG raised its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 35.9% during the 2nd quarter, according to its most recent disclosure with...
MarketBeat·4d ago
News Placeholder
Candriam S.C.A. Has $28.64 Million Stock Holdings in Ionis Pharmaceuticals, Inc. $IONS
Candriam S.C.A. decreased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 27.1% during the 2nd quarter, according to the company in its most recent 13F filing...
MarketBeat·8d ago
News Placeholder
Ionis Pharmaceuticals (NASDAQ:IONS) Sees Strong Trading Volume - Still a Buy?
Ionis Pharmaceuticals (NASDAQ:IONS) Sees Unusually-High Trading Volume - What's Next...
MarketBeat·9d ago
News Placeholder
DAWNZERA (donidalorsen) receives positive opinion from CHMP, recommended for approval in EU for hereditary angioedema (HAE)
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
Business Wire·9d ago
News Placeholder
Fox Run Management L.L.C. Takes $434,000 Position in Ionis Pharmaceuticals, Inc. $IONS
Fox Run Management L.L.C. acquired a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the second quarter, according to the company in its most recent filing with...
MarketBeat·9d ago
News Placeholder
Leerink Partnrs Has Pessimistic View of IONS FY2027 Earnings
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) - Equities research analysts at Leerink Partnrs reduced their FY2027 earnings per share (EPS) estimates for Ionis Pharmaceuticals in a report...
MarketBeat·10d ago

Latest IONS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.